Cord blood trial for stroke and spinal injury pulled before it began

NCT ID NCT05515419

Terminated Disease control Sponsor: The Medical Pavilion Bahamas Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study planned to test whether donated umbilical cord blood could help adults with stroke or spinal cord injury. However, the trial was withdrawn before enrolling any participants, so no data or results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Allogeneic cord blood (donated umbilical cord blood cells)

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMORRHAGIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemorrhagic stroke ischemic stroke nervous system disorder spinal cord injury stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROLOGICAL DISEASES SPINAL CORD INJURIES STROKE

More trials for these conditions

Other studies related to the condition(s) this trial covers.